ArticleSkin appendage disorders2026
Association between Onychogryphosis and Lower Extremity Complications: A Multicenter Cohort Study Using TriNetX.
Article in Skin appendage disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Onychogryphosis has been associated with chronic foot injury and vascular disease. We evaluated whether onychogryphosis is associated with increased 5-year risk of lower extremity complications. Methods: Using TriNetX Research Network patients with onychogryphosis were propensity score matched 1:1 to controls for age, sex, race, obesity, type II diabetes, chronic kidney disease, and smoking. Cox proportional hazards models estimated 5-year hazard ratios (HRs) for lower extremity complications, with subgroup analyses for diabetes and peripheral artery disease (PAD). Results: After matching (174,537 per cohort), onychogryphosis was associated with increased 5-year risk of foot/toe amputation procedures (HR 2.798, 95% CI: 2.516-3.111), ulcer (HR 2.108, 95% CI: 2.023-2.196), cellulitis (HR 1.743, 95% CI: 1.685-1.803), osteomyelitis (HR 1.673, 95% CI: 1.583-1.769), and gangrene (HR 1.485, 95% CI: 1.382-1.597) (all Conclusion: Onychogryphosis was associated with substantially increased 5-year risk of major lower extremity complications in a large matched cohort, with consistent findings among patients with type II diabetes and PAD. Identification of onychogryphosis should prompt focused lower extremity assessment and brief risk screening with a low threshold for vascular or primary care referral in high-risk patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.